Skip to search formSkip to main contentSkip to account menu

sorivudine

Known as: 5-(2-bromovinyl)-1-beta-D- arabinofuranosyluracil, 2,4(1H,3H)-Pyrimidinedione, 1-beta-D-arabinofuranosyl-5-(2-bromoethenyl)-, (E)-, 1-beta-D-arabinofuranosyl-5-(2-bromovinyl)uracil 
A synthetic thymidine analogue with potent antiviral activity against herpes simplex and varicella zoster viruses. Sorivudine is phosphorylated into… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
BACKGROUND: EGFRvIII, a constitutively active tumorigenic EGFR deletion mutation, is linked to poor long-term survival. The… 
2000
Review
1993
Review
1993
Varicella in the immunocompetent adult is an infrequent but potentially serious infection. Previous studies in immunocompetent… 
1991
1991
We evaluated the treatment of varicella-zoster infection with BV-araU in immuno-compromised patients with haematological… 
1990
1990
Susceptibilities to brovavir [l‐β‐D‐arabinofuranosyl‐E‐5‐(2‐bromovinyl)‐uracil] and acyclovir of clinical isolates of varicella… 
1984
1984
Strains of varicella-zoster virus resistant to 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) were isolated from… 
1979
1979
Several 5-alkyl derivatives of 1-β-d-arabinofuranosyluracil (araU) were tested for antiherpesviral activity and inhibitory action…